TCT 2021 | Healthcare utilization & end of life outcomes in patients receiving CAR-T

Connor Johnson, MD, Massachusetts General Hospital & Harvard Medical School, Boston, MA, outlines the results of a retrospective analysis evaluating the impact of CAR T-cell therapy on healthcare utilization and end-of-life outcomes. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.